TNGX

NASDAQ · Biotechnology

Tango Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$20.98

-0.64 (-2.96%)

As of May 9, 1:33 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target +34.6% upside

Low Target $22.54

Average Target $28.24

High Target $42.65

Current Price $20.98

Current
$20.98

Target
$28.24

$22.54 $28.24 avg $42.65

Scenario Analysis

Bear Case

$22.54

7.4%

Low target

Base Case

$28.24

+34.6%

Avg target

Bull Case

$42.65

+103.3%

High target

Risk/Reward

13.9x

Highly favorable

Price in Context

52-Week High

$28.41

-26.2% from high

52-Week Low

$1.03

+1,936.9% from low

Target vs 52W High

$28.24

-0.6% vs high

Next Earnings Report

May 13, 2026

until earnings

EPS Est: $-0.32

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%